Immunology of DNA vaccines: CpG motifs and antigen presentation

Inflammation Research

Volumn 49, Issue 5, 2000, Pages 199-205

  Manders, P ^a   Thomas, R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

DNA; Immunology; Mechanism; Plasmid; Vaccines

Indexed keywords

BACTERIAL DNA; CYTOKINE; DNA VACCINE; PLASMID DNA;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; CPG ISLAND; DNA SEQUENCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOSTIMULATION; MODEL; NONHUMAN; PLASMID; REVIEW; VACCINATION;

ANIMALS; ANTIGENS; CPG ISLANDS; DNA; HUMANS; PLASMIDS; VACCINES, DNA;

EID: 0034044460     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050580     Document Type: Review

References (52)

1. [1] Boyer JD, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination [see comments]. Nat Med 1997; 3: 526-32.
2. [2] Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ et al. Heterologous protection against influenza by injection of DNA encoding a viral protein [see comments]. Science 1993; 259: 1745-9.
3. [3] Xu L, Sanchez A, Yang Z, Zaki SR, Nabel EG, Nichol ST et al. Immunization for Ebola virus infection [see comments]. Nat Med 1998; 4: 37-42.
4. [4] Lowrie DB, Silva CL, Colston MJ, Ragno S, Tascon RE. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine 1997; 15: 834-8.
5. [5] King CA, Spellerberg MB, Zhu D, Rice J, Sahota SS, Thompsett AR et al. DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma [see comments]. Nat Med 1998; 4: 1281-6.
6. [6] Calarota S, Bratt G, Nordlund S, Hinkula J, Leandersson AC, Sandstrom E et al. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 1998; 351: 1320-5.
7. [7] Wang R, Doolan DL, Le TP, Hedstrom RC, Coonan KM, Charoenvit Y et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 1998; 282: 476-80.
8. [8] MacGregor RR, Boyer JD, Ugen KE, Lacy KE, Gluckman SJ, Bagarazzi ML et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis 1998; 178: 92-100.
9. [9] Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-8.
10. [10] Yamamoto S, Kuramoto E, Shimada S, Tokunaga T. In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn J Cancer Res 1988; 79: 866-73.
11. [11] Shimada S, Yano O, Inoue H, Kuramoto E, Fukuda T, Yamamoto H et al. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. J Natl Cancer Inst 1985; 74: 681-8.
12. [12] Yi AK, Chace JH, Cowdery JS, Krieg AM. IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. J Immunol 1996; 156: 558-64.
13. [13] Tokunaga T, Yano O, Kuramoto E, Kimura Y, Yamamoto T, Kataoka T et al. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol Immunol 1992; 36: 55-66.
14. [14] Cowdery JS, Chace JH, Yi AK, Krieg AM. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol 1996; 156: 4570-5.
15. [15] Jiao S, Williams P, Berg RK, Hodgeman BA, Liu L, Repetto G et al. Direct gene transfer into nonhuman primate myofibers in vivo. Hum Gene Ther 1992; 3: 21-33.
16. [16] Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321: 209-13.
17. [17] Klinman DM, Yamshchikov G, Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 1997; 158: 3635-9.
18. [18] Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen MD et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996; 273: 352-4.
19. [19] Wloch MK, Pasquini S, Ertl HC, Pisetsky DS. The influence of DNA sequence on the immunostimulatory properties of plasmid DNA vectors. Hum Gene Ther 1998; 9: 1439-47.
20. [20] Weeratna R, Brazolot Millan CL, Krieg AM, Davis HL. Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev 1998; 8: 351-6.
21. [21] Krieg AM. An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA. J Lab Clin Med 1996; 128: 128-33.
22. [22] Yi AK, Klinman DM, Martin TL, Matson S, Krieg AM. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J Immunol 1996; 157: 5394-402.
23. [23] Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 1998; 160: 5898-906.
24. [24] Stacey KJ, Sweet MJ, Hume DA. Macrophages ingest and are activated by bacterial DNA. J Immunol 1996; 157: 2116-22.
25. [25] Sweet MJ, Stacey KJ, Kakuda DK, Markovich D, Hume DA. IFN-gamma primes macrophage responses to bacterial DNA. J Interferon Cytokine Res 1998; 18: 263-71.
26. [26] Sparwasser T, Koch ES, Vabulas RM, Heeg K, Lipford GB, Ellwart JW et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 1998; 28: 2045-54.
27. [27] Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 1998; 161: 3042-9.
28. [28] Ballas ZK, Rasmussen WL, Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996; 157: 1840-5.
29. [29] McCluskie MJ, Davis HL. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J Immunol 1998; 161: 4463-6.
30. [30] Roman M, Martin Orozco E, Goodman JS, Nguyen MD, Sato Y, Ronaghy A et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants [see comments]. Nat Med 1997; 3: 849-54.
31. [31] Leclerc C, Deriaud E, Rojas M, Whalen RG. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA. Cell Immunol 1997; 179: 97-106.
32. [32] Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997; 186: 1623-31.
33. [33] Davis HL, Weeranta R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 1998; 160: 870-6.
34. [34] Feltquate DM, Heaney S, Webster RG, Robinson HL. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997; 158: 2278-84.
35. [35] Haynes JR, McCabe DE, Swain WF, Widera G, Fuller JT. Particle-mediated nucleic acid immunization. J Biotechnol 1996; 44: 37-42.
36. [36] Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D, Maraskovsky E et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 1999; 96: 1036-41.
37. [37] Mantegazza R, Hughes SM, Mitchell D, Travis M, Blau HM, Steinman L. Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma [see comments]. Neurology 1991; 41: 1128-32.
38. [38] Young JW, Steinman RM. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells. Journal of Experimental Medicine 1990; 171: 1315-32.
39. [39] Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci U S A 1994; 91: 9519-23.
40. [40] Chattergoon MA, Robinson TM, Boyer JD, Weiner DB. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J Immunol 1998; 160: 5707-18.
41. [41] Casares S, Inaba K, Brumeanu T-D, Steinman RM, Bona CA. Antigen presentation by dendritic cells after immunization with DNA enoding a major histocompatibility complex class II-restricted viral epitope. J Exp Med 1997; 186: 1481-6.
42. [42] Tsuji T, Hamajima K, Fukushima J, Xin KQ, Ishii N, Aoki I et al. Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J Immunol 1997; 158: 4008-13.
43. [43] Svanholm C, Lowenadler B, Wigzell H. Amplification of T-cell and antibody responses in DNA-based immunization with HIV-1 Nef by co-injection with a GM-CSF expression vector. Scand J Immunol 1997; 46: 298-303.
44. [44] Iwasaki A, Stiernholm BJ, Chan AK, Berinstein NL, Barber BH. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 1997; 158:4591-601.
45. [45] Boyle JS, Brady JL, Lew AM. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 1998;392:408-11.
46. [46] Doe B, Selby M, Barnett S, Baenziger J, Walker CM. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci U S A 1996;93:8578-83.
47. [47] Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, Kosaka H. Constitutive class I-restricted exogenous presentation of self anti-gens in vivo. J Exp Med 1996;184:923-30.
48. [48] Fu TM, Ulmer JB, Caulfield MJ, Deck RR, Friedman A, Wang S et al. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med 1997; 3: 362-71.
49. [49] Ulmer JB, Deck RR, DeWitt CM, Fu TM, Donnelly JJ, Caulfield MJ et al. Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity. Vaccine 1997; 15: 839-41.
50. [50] Klinman DM, Sechler JM, Conover J, Gu M, Rosenberg AS. Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. J Immunol 1998; 160: 2388-92.
51. [51] Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD, Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996; 2: 1122-8.
52. [52] Hill S, Edwards AJ, Kimber I, Knight SC. Systemic migration of dendritic cells during contact sensitization. Immunology 1990; 71: 277-81.